Another pathway significantly affected by Psen1KI/KI was the ERK/MAPK signaling pathway (−log p 9.61) which has been shown to be specifically activated in microglia in a pre-clinical model of AD pathology and human post-mortem AD brains [29]. Here, PSME3 is linked to Alzheimer disease.